New cancer vaccine uses SARS-CoV-2 marker to harness immunity against tumors

Image: Confocal image of B16F10 cells expressing RBD antigen. Image credit Xun Sun et al. Article by Bradley van Paridon. Advanced Science News – March 4, 2025. Research article: Advanced Materials.

A potential new cancer treatment labels tumors with a piece of the SARS-CoV-2 virus, unleashing the patient’s own immune system onto the cancerous cells. The widespread exposure to the SARS-CoV-2 virus — whether through vaccination or infection has primed immune systems to recognize and attack coronavirus proteins. As a result, most people […]

Click here to view original web page at www.advancedsciencenews.com